Therapeutic Agents in Phase I Clinical Trials for Alzheimer’s Disease

Slides:

Advertisements

Similar presentations

1Kitasato-Harvard Symposium 10/03/2002 New Monoclonal Antibody Approved for Advanced Breast Cancer Shin-ichi Nihira, Ph.D. Dept. Clinical Research 3 Chugai.

Advertisements

Phase Difference = Phase Difference = 0.05.

Turning TypeOne to The Plan for a World without T1D.

HCG METABOLIC FAT LOSS PROGRAM. WEEK 10 The Challenge of Adding More Foods.

Prof. Erik Lu. MORPHOLOGY GRAMMAR MORPHOLOGY MORPHEMES BOUND FREE WORDS LEXICAL GRAMMATICAL NOUNS VERBS ADJECTIVES (ADVERBS) PRONOUNS ARTICLES ADVERBS.

1 Carbon! Why it’s cool, and what it can do. 2 ORGANIC = FROM A LIVING SOURCE, OR CONTAINING CARBON The fact that Carbon needs 4 electrons to complete.

BY NKEM UMEOKOLI MSc Neuropharmacology University of East London

Alzheimer’s Disease -> The Disease of Darkness Varun Doshi.

Cloning. What is cloning? Cloning is the process of making a genetically identical organism or cell through nonsexual means.

The Science of Embryonic Stem Cells by Arun Bharatula.

Adding SubtractingMultiplyingDividingMiscellaneous.

Chef Lucy’s Fresh Fruits and Vegetables WHITE GRAPES.

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.

What we are learning about Alzheimer’s disease genetics Bryan J. Traynor.

Main Function: Communicates /controls actions of other glands and organs by the secretion of hormones. Gland - A cell, group of cells, or organ that produces.

Pathogenesis and biological interventions in T1DM- LIKE autoimmune diabetes- Insulitis The class I MHC molecules are hyperexpressed on the β-cell surface.

 (1) recombinant DNA technology or DNA cloning,  (2) reproductive cloning  (3) therapeutic cloning.

Presented By Michele Cavo at 2016 ASCO Annual Meeting

Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)

Human Mesenchymal Stem Cell & Culture System

Transformation Chapter 12.

Figure 3. Effect of LHRH-A (10−6m) on the IGF-I-induced tyrosine phosphorylation of the IGF-IR in DU 145 cells. LHRH-A was added to the experimental.

Alzheimer's disease drug development pipeline: 2017

Presented By Luca Malorni at 2017 ASCO Annual Meeting

CB2 Topic 7 Animal Coordination, Control and Homeostasis.

For related symptoms: AVP-786 (agitation): NMDA receptor antagonist

Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.

Therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer a.

Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.

Aducanumab: amyloid antibody Biogen

Patient Case 1 Peggy Peggy Interactive Case Question.

Role of Chemotherapy in the Current Treatment Paradigm for Men With CRPC.

Modifying Disease Course in Alzheimer's Disease

Current Controversies in Multiple Sclerosis Management

Therapeutic Agents in Phase II Clinical Trials for Alzheimer’s Disease

A review of the new Eversense CGM System

A list of 289 proteins whose detection in plasma or serum is documented in the literature “Steady-state” forms are listed, but cleavage products formed.

Cancer Stem Cell Therapies in Gastrointestinal Cancers

Novara Italy Expertise in:

Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.

מרכיבי הדם.

Alzheimer's disease drug development pipeline: 2018

Recombinant DNA Technology

UK ABC-02 trial: Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter,

Oral Anticoagulation in AF

Volume 20, Issue 6, Pages (June 2017)

Therapeutic Agents in Phase II Clinical Trials for Alzheimer’s Disease

Conjugates Standard form of Complex Numbers

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Amyloid Structures from Alzheimer’s Disease Patients

Managing Patients with Relapsed CLL who Discontinue BCR Signaling Inhibitors.

Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial

-.&- ·Af& Q 0 "i'/

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

Adding with 9’s.

Adding with 10’s.

A. Bryskier Clinical Microbiology and Infection

Varman T. Samuel, Gerald I. Shulman Cell Metabolism

A Template for New Drugs against Alzheimer’s Disease

Amyloid Structures from Alzheimer’s Disease Patients

Dhavalkumar D. Patel, Vijay K. Kuchroo Immunity

If AD = 10, DC =6, and ED = 15, find DB.

Learning outcomes Hormones are secreted by glands and are transported to their target organs by the bloodstream. Several hormones are involved in the.

Adding ____ + 10.

Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines.

Regulation of insulin-like growth factor binding protein secretion by human granulosa luteal cells in a polycystic ovary-like environment Susanne Greisen,

Homework Solutions.

We surveyed 100 people and asked them ‘what would you find in blood’?

THE GROWTH ENVIRONMENT.

Presentation transcript:

Therapeutic Agents in Phase I Clinical Trials for Alzheimer’s Disease ABT-957 ABvac42 AD-SVF (stem cells) Aducanumab Allopregnanolone AstroStem (stem cells) BI 409306BIIB076 Bisnorcymserine (BNC) Bosutinib CB-AC-02 (stem cells) Crenezumab CT1812 Elderberry Juice Escitalopram Growth hormone releasing hormone Insulin aspart IONIS MAPTRx Ketogenic medium chain triglyceride drink KHK6640 LM11A-31-BHS LMSC (stem cells) Lu AF20513 LY3002813 LY3303560 NeuroStem (stem cells) NP001 NPT088 Oxaloacetate (OAA) PF-05251749 PF-06648671 Posiphen® Probucol Resveratrol RG6100 RGN1016 RO7105705 Salsalate S-Equol SUVN-G3031 T3D-959 TAK-071 Telmisartan TPI 287 UCMSC (stem cells) Venlafaxine Verubecestat Vorinostat VU319 As of 10/2017